Success Stories

Stories tagged: Laurentian

  • RNA Diagnostics team

    Rna Diagnostics Inc.

    Currently, just 25 per cent of breast cancer patients have a long-term survival benefit from chemotherapy treatments. However, determining whether or not the treatment is working takes multiple chemotherapy cycles, which can cause patient suffering and burden the health care system.